Design of multitarget drugs and polypharmacological compounds has become popular during the past decade. However, the main approach to design such compounds is to link two selective ligands via a flexible linker. Although such chimeric ligands often have reasonable potency in vitro, the in vivo efficacy is low due to high molecular weight, low ligand efficiency, and poor pharmacokinetic profile. We developed an unprecedented in silico approach for fragment-based design of multitarget ligands. It relies on superposition of the chemical spaces related to the affinity on single targets represented by self-organizing maps. We used this approach for screening of molecular fragments, which bind to the enzymes 5-lipoxygenase (5-LO) and soluble epo...
Over the last two decades polypharmacology has emerged as a new paradigm in drug discovery, even tho...
Dual- or multi-target ligands have gained increased attention in the past years due to several advan...
Over the past two decades the “one drug – one target – one disease” concept became the prevalent par...
Design of multitarget drugs and polypharmacological compounds has become popular during the past dec...
Designed multitarget ligands are a popular approach to generating efficient and safe drugs, and frag...
Dual-target inhibitors gained increased attention in the past years. A novel in silico approach was ...
Predicting the macromolecular targets of drug-like molecules has become everyday practice in medicin...
The discovery of multitarget drugs has recently attracted much attention. Most of the reported multi...
Flexibility, structural adaptability and non-selective pharmacophoric features of ligands and macrom...
Abstract: We present a self-organizing map (SOM) approach to predicting macromolecular targets for c...
We present a self-organizing map (SOM) approach to predicting macromolecular targets for combinatori...
These authors contributed equally to this work. One common practice in drug discovery is to opti-miz...
A natural product collection and natural-product-derived combinatorial libraries were virtually scre...
The development of new bioactive compounds represents one of the main purposes of the drug discovery...
Structure-based drug design (SBDD) is a powerful and widely used approach to optimize affinity of dr...
Over the last two decades polypharmacology has emerged as a new paradigm in drug discovery, even tho...
Dual- or multi-target ligands have gained increased attention in the past years due to several advan...
Over the past two decades the “one drug – one target – one disease” concept became the prevalent par...
Design of multitarget drugs and polypharmacological compounds has become popular during the past dec...
Designed multitarget ligands are a popular approach to generating efficient and safe drugs, and frag...
Dual-target inhibitors gained increased attention in the past years. A novel in silico approach was ...
Predicting the macromolecular targets of drug-like molecules has become everyday practice in medicin...
The discovery of multitarget drugs has recently attracted much attention. Most of the reported multi...
Flexibility, structural adaptability and non-selective pharmacophoric features of ligands and macrom...
Abstract: We present a self-organizing map (SOM) approach to predicting macromolecular targets for c...
We present a self-organizing map (SOM) approach to predicting macromolecular targets for combinatori...
These authors contributed equally to this work. One common practice in drug discovery is to opti-miz...
A natural product collection and natural-product-derived combinatorial libraries were virtually scre...
The development of new bioactive compounds represents one of the main purposes of the drug discovery...
Structure-based drug design (SBDD) is a powerful and widely used approach to optimize affinity of dr...
Over the last two decades polypharmacology has emerged as a new paradigm in drug discovery, even tho...
Dual- or multi-target ligands have gained increased attention in the past years due to several advan...
Over the past two decades the “one drug – one target – one disease” concept became the prevalent par...